Drug intelligence / Profile preview

benidipine

Development stage
Phase 4
Lead developer
Kyowa Kirin
Modality
Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Benidipine is a synthetic dihydropyridine calcium channel blocker primarily used for the treatment of hypertension and angina pectoris. It acts as a triple calcium channel inhibitor by blocking L-type, N-type, and T-type voltage-dependent calcium channels. This broad inhibition leads to vasodilation and reduced blood pressure. In addition to its antihypertensive effects, benidipine exhibits cardioprotective and renoprotective properties—partly through stimulation of nitric oxide production and suppression of vascular smooth muscle proliferation. Notably, it also functions as an antagonist of the mineralocorticoid receptor (antimineralocorticoid), contributing further to its cardiovascular benefits. Developed in Japan by Kyowa Hakko (now Kyowa Kirin), it is marketed in several Asian countries including Japan and India[1][5][6][7][10].

Brand names
ConielCaritecBeniprime
Other names
benidipine hydrochlorideBenidipinumBenidipinoNacadipineNakadipine
02

Targets

CACNA1B (Voltage-dependent N-type calcium channel subunit alpha-1B)CACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)CaV3 (Caveolin-3)MR (Mineralocorticoid receptor)

Beyond the preview

Go deeper on benidipine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on benidipine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call